The Thai Phase III HIV Type 1 Vaccine Trial (RV144) Regimen Induces Antibodies That Target Conserved Regions Within the V2 Loop of gp120

Nicos Karasavvas; Erik Billings; Mangala Rao; Constance Williams; Susan Zolla-Pazner; Robert T. Bailer; Richard A. Koup; Sirinan Madnote; Duangnapa Arworn; Xiaoying Shen; Georgia D. Tomaras; Jeffrey R. Currier; Mike Jiang; Craig Magaret; Charla Andrews; Raphael Gottardo; Peter Gilbert; Timothy J. Cardozo; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Punnee Pitisuttithum; Jaranit Kaewkungwal; Robert Paris; Kelli Greene; Hongmei Gao; Sanjay Gurunathan; Jim Tartaglia; Faruk Sinangil; Bette T. Korber; David C. Montefiori; John R. Mascola; Merlin L. Robb; Barton F. Haynes; Viseth Ngauy; Nelson L. Michael; Jerome H. Kim; Mark S. de Souza, for the MOPH TAVEG Collab

doi:10.1089/aid.2012.0103

The Thai Phase III HIV Type 1 Vaccine Trial (RV144) Regimen Induces Antibodies That Target Conserved Regions Within the V2 Loop of gp120

AIDS Research and Human Retroviruses ◽

10.1089/aid.2012.0103 ◽

2012 ◽

Vol 28 (11) ◽

pp. 1444-1457 ◽

Cited By ~ 143

Author(s):

Nicos Karasavvas ◽

Erik Billings ◽

Mangala Rao ◽

Constance Williams ◽

Susan Zolla-Pazner ◽

...

Keyword(s):

Vaccine Trial ◽

Phase Iii ◽

Conserved Regions ◽

Hiv Type 1

Download Full-text

Molecular Epidemiology of HIV Type 1 in Preparation for a Phase III Prime-Boost Vaccine Trial in Thailand and a New Approach to HIV Type 1 Genotyping

AIDS Research and Human Retroviruses ◽

10.1089/aid.2006.22.801 ◽

2006 ◽

Vol 22 (8) ◽

pp. 801-807 ◽

Cited By ~ 14

Author(s):

Veerachai Watanaveeradej ◽

Michael W. Benenson ◽

Mark De Souza ◽

Narongrid Sirisopana ◽

Sorachai Nitayaphan ◽

...

Keyword(s):

Molecular Epidemiology ◽

Vaccine Trial ◽

Phase Iii ◽

New Approach ◽

Boost Vaccine ◽

Hiv Type 1

Download Full-text

Enhanced Sensitivity of Detection of Cytotoxic T Lymphocyte Responses to HIV Type 1 Proteins Using an Extended In Vitro Stimulation Period for Measuring Effector Function in Volunteers Enrolled in an ALVAC-HIV Phase I/II Prime Boost Vaccine Trial in Thailand

AIDS Research and Human Retroviruses ◽

10.1089/0889222041217473 ◽

2004 ◽

Vol 20 (6) ◽

pp. 642-644 ◽

Cited By ~ 5

Author(s):

Wannee Kantakamalakul ◽

Mark De Souza ◽

Chitraporn Karnasuta ◽

Arthur Brown ◽

Sanjay Gurunathan ◽

...

Keyword(s):

T Lymphocyte ◽

Cytotoxic T Lymphocyte ◽

Vaccine Trial ◽

Enhanced Sensitivity ◽

Boost Vaccine ◽

Stimulation Period ◽

Hiv Type 1 ◽

Lymphocyte Responses

Download Full-text

Pediatric HIV Type 1 Vaccine Trial Acceptability among Mothers in Kenya

AIDS Research and Human Retroviruses ◽

10.1089/aid.2006.22.491 ◽

2006 ◽

Vol 22 (6) ◽

pp. 491-495 ◽

Cited By ~ 8

Author(s):

Carey Farquhar ◽

Grace C. John-Stewart ◽

Francis N. John ◽

Marjory N. Kabura ◽

James N. Kiarie

Keyword(s):

Vaccine Trial ◽

Pediatric Hiv ◽

Hiv Type 1

Download Full-text

Novel and Promiscuous CTL Epitopes in Conserved Regions of Gag Targeted by Individuals with Early Subtype C HIV Type 1 Infection from Southern Africa

The Journal of Immunology ◽

10.4049/jimmunol.173.7.4607 ◽

2004 ◽

Vol 173 (7) ◽

pp. 4607-4617 ◽

Cited By ~ 43

Author(s):

Agatha M. Masemola ◽

Tumelo N. Mashishi ◽

Greg Khoury ◽

Helba Bredell ◽

Maria Paximadis ◽

...

Keyword(s):

Southern Africa ◽

Subtype C ◽

Ctl Epitopes ◽

Conserved Regions ◽

Hiv Type 1

Download Full-text

Molecular Characterization of HIV Type 1 Among HIV-Infected Respondents in a Cohort Being Prepared for HIV Phase III Vaccine Clinical Trials, Western Kenya

AIDS Research and Human Retroviruses ◽

10.1089/aid.2010.0061 ◽

2011 ◽

Vol 27 (3) ◽

pp. 257-264 ◽

Cited By ~ 3

Author(s):

Micah Oyaro ◽

John Mbithi ◽

Fred Oyugi ◽

Annette Laten ◽

Omu Anzala ◽

...

Keyword(s):

Clinical Trials ◽

Molecular Characterization ◽

Phase Iii ◽

Western Kenya ◽

Hiv Type 1

Download Full-text

Prevalence of HIV Type 1 Infection, Associated Clinical Features and Mortality among Hospitalized Children in Dar es Salaam, Tanzania

Scandinavian Journal of Infectious Diseases ◽

10.1080/003655400750044917 ◽

2000 ◽

Vol 32 (4) ◽

pp. 357-363 ◽

Cited By ~ 11

Author(s):

Grace Kawo, Katarina Karlsson, Eligius Ly

Keyword(s):

Clinical Features ◽

Dar Es Salaam ◽

Hospitalized Children ◽

Hiv Type 1

Download Full-text

Faculty Opinions recommendation of Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1006121.76307 ◽

2002 ◽

Author(s):

William Evan Secor

Keyword(s):

Human Immunodeficiency Virus ◽

Disease Progression ◽

Large Cohort ◽

Immunodeficiency Virus ◽

Hiv Type 1 ◽

Hiv 1

Download Full-text

Faculty Opinions recommendation of Contribution of immunological and virological factors to extremely severe primary HIV type 1 infection.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1147094.604930 ◽

2009 ◽

Author(s):

J Michael Kilby

Keyword(s):

Hiv Type 1

Download Full-text

Faculty Opinions recommendation of CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1139018.596123 ◽

2008 ◽

Author(s):

Caroline Sabin

Keyword(s):

T Cell ◽

Antiretroviral Therapy ◽

Cell Count ◽

Cd4 T Cell ◽

Hiv Type 1 ◽

Cd4 T Cell Count ◽

Count Recovery

Download Full-text

Faculty Opinions recommendation of Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.14292.471794 ◽

2006 ◽

Author(s):

Ann Duerr

Keyword(s):

Viral Load ◽

High Risk ◽

Plasma Viral Load ◽

African Women ◽

Set Point ◽

Acute Hiv ◽

Hiv Type 1 ◽

Hiv 1

Download Full-text